R. Brooks Robey, MD
Associate Professor of Medicine
• Associate Chief of Staff for Research, White River Junction VAMC
• Staff Nephrologist (Founding Section Chief, 2009-2014), Section of Nephrology and Hypertension, White River Junction VAMC
• Director (Inaugural Director 2013-2016), Northern New England Research Consortium (White River Junction VAMC [VT], Manchester VAMC [NH], VA Maine HCS [ME], and Central Western Massachusetts VAMC [MA])
• B.S. with Honors in Chemical Biology, Rhodes College (1981)
• M.D., University of Arkansas for Medical Sciences (1985)
• Intern, Internal Medicine, University of Arkansas (1985-1986)
• Resident, Internal Medicine, University of Arkansas (1986-1988)
• Research Fellow, Molecular Physiology, LKEM, NHLBI, NIH (1988-1991)
• Clinical Fellow, Nephrology, Vanderbilt University (1991-1994)
• Research Fellow, Molecular Physiology, Vanderbilt University (1992-1996)
Program in Experimental and Molecular Medicine
c/o WRJVAMC R&D Svc (151)
215 N Main St
White River Jct VT 05009-0001
• Co-Director, Renal Physiology
• Scientific Basis of Medicine (SBM), Kidney & Urinary System (KUS)
• Advanced Medical Sciences (AMS)
• Co-Director, VA Cardiorenal ECHO Program (VISN 1)
• VA Renal ECHO Program (VISN 20)
Dr. Robey received his B.S. with Honors in Chemical Biology at Rhodes College in 1981 and his M.D. at the University of Arkansas in 1985. Following graduate medical training in Internal Medicine at the University of Arkansas (1985-1988), he completed a postdoctoral research fellowship in Molecular Physiology in the Laboratory of Kidney and Electrolyte Metabolism at NHLBI/NIH (1988-1991). He then completed additional graduate medical training in Nephrology (1991-1994) and a second postdoctoral research fellowship in Molecular Physiology (1993-1996) at Vanderbilt University. After nearly a decade on the faculty of the University of Illinois College of Medicine, he relocated to the Geisel School of Medicine at Dartmouth in 2005, where he is presently an Associate Professor of Medicine and of Medical Education, a member of the faculty of the Program for Experimental and Molecular Medicine (PEMM), and Associate Chief of Staff for Research and Development at Dartmouth’s affiliate Veterans Affairs (VA) Medical Center in White River Junction. He is presently Co-Director of the Renal Physiology curriculum and an active participant in the Kidney & Urinary System (KUS) section of the Scientific Basis of Medicine (SBM) course.
He is an active practicing clinician at the White River Junction VA Medical Center, where he was the Founding Chief of the Section of Nephrology and Hypertension (2010-2014) and still serves as a staff physician and participates in the full spectrum of undergraduate and graduate medical education activities. He is board-certified in both Internal Medicine and Nephrology (ABIM) and is a certified Specialist in Clinical Hypertension (AHSCP-CHS). In addition, he is an elected Member of the Central Society for Clinical and Translational Research and an elected Fellow of the American Society of Nephrology (FASN), the American Heart Association’s Council on the Kidney in Cardiovascular Disease (FAHA), the American Physiological Society (FAPS), the National Kidney Foundation (FNKF), and the American College of Physicians (FACP). He is also an active clinician scientist with interests in both clinical research and the molecular mechanisms whereby metabolism influences cellular injury susceptibility and cell survival.
Adverse Effects of Low-Dose Methotrexate.
Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis.
CD36-Mediated Metabolic Rewiring of Breast Cancer Cells Promotes Resistance to HER2-Targeted Therapies.
Perspectives from the Kidney Health Initiative on Advancing Technologies to Facilitate Remote Monitoring of Patient Self-Care in RRT.
Chronic Kidney Disease Progression and Cardiovascular Outcomes Following Cardiac Catheterization-A Population-Controlled Study.
Designing a broad-spectrum integrative approach for cancer prevention and treatment.
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.
Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?
Varenicline for smoking reduction prior to cessation.
Cyclical dehydration-induced renal injury and Mesoamerican nephropathy: as sweet by any other name?